Valoctocogene roxaparvovec for treating severe haemophilia A [ID3806]

Status:

Awaiting development

Decision:

None selected

Process:

TA

ID number:

3806

Timeline

Key events during the development of the guidance:

For further information on our processes and methods, please see our CHTE processes and methods manual